Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:17 PM ET 8-K
M&A Deal Luxfer Holdings PLC LXFR

Luxfer Holdings M&A Deal with Double Eagle Acquisition Buyer, Inc.

Luxfer Holdings PLC provided a status update regarding its pending acquisition by Double Eagle Acquisition Buyer, Inc., an entity owned by Wynnchurch Capital. The company is issuing supplemental proxy disclosures to address two shareholder lawsuits and several demand letters alleging disclosure deficiencies in the definitive proxy statement. The shareholder meetings to vote on the transaction remain scheduled for November 4, 2026.

Counterparty
Double Eagle Acquisition Buyer, Inc.
5:16 PM ET 8-K
Loan & Debt West Pharmaceutical Services Inc WST

West Pharmaceutical Services $200M Debt Financing with Bank of America, N.A.

West Pharmaceutical Services entered into a new $950 million credit facility consisting of a $750 million revolving credit facility and a $200 million term loan. The proceeds were used to repay $130 million outstanding under its previous 2019 credit agreement, which was subsequently terminated. The new facility has a five-year term and will be used for working capital, capital expenditures, and general corporate purposes.

Value
$200M
Counterparty
Bank of America, N.A.
Term
5 years
5:16 PM ET 8-K
Capacity Expansion Venu Holding Corp VENU

Venu Holding Capacity Expansion: $35M Investment

Venu Holding Corp entered into a series of agreements for the continued development and financing of 'The Sunset McKinney,' a major open-air amphitheater and entertainment complex in Texas. The transaction includes an amended development agreement with the City of McKinney and a sale-leaseback arrangement with STORE Capital involving the 46-acre project site. The project was previously supported by a $35 million land acquisition involving a $25 million promissory note to the McKinney Economic Development Corporation.

Value
$35M
Counterparty
City of McKinney, Texas
5:14 PM ET 8-K
Leadership Change Green Brick Partners, Inc. GRBK

Green Brick Partners Leadership Change

Green Brick Partners appointed its Co-Chief Executive Officer, Jed Dolson, to the Board of Directors, effective October 22, 2026. Concurrently with his appointment, the Board was expanded from six to seven directors. Mr. Dolson will serve a term expiring at the 2027 Annual Meeting of Stockholders.

5:12 PM ET 10-Q
Financial Results Audioeye Inc AEYE

Audioeye Q3 2026 Results: Turns Profitable, Net Income $990K

AudioEye reported a net income of $0.99 million for the third quarter of 2026, a significant improvement from a net loss of $0.55 million in the prior year period. Total revenue grew to $10.96 million for the quarter, while the company maintained a strong cash position of $9.33 million as of September 30, 2026.

Key figure
Net income $990K
5:11 PM ET Form 4
Insider Buying Byline Bancorp, Inc. BY

Byline Bancorp Director Pamela C. Stewart Buys $44.8K of Stock

Pamela C. Stewart, Director, bought 1,160 shares of Byline Bancorp, Inc. at $38.61 a share, worth $44.8K in total on Oct 26, 2026. Shares held after the trade: 7,496 (+18.3%).

Value
$44.8K
Shares
1,160
Price
$38.61
Role
Director
Holding change
+18.3%
Trade date
Oct 26, 2026
5:10 PM ET 8-K
Leadership Change Cycurion, Inc. CYCU

Cycurion Leadership Change

Cycurion, Inc. appointed J. Derek Penn to its Board of Directors and its Audit, Compensation, and Nominating committees, effective October 20, 2026. Simultaneously, Peter R. Ginsberg stepped down from all board committees after it was determined he no longer met independence requirements due to his role as outside legal counsel, though he remains a director.

5:09 PM ET 8-K
Capital Raise Equillium, Inc. EQ

Equillium Capital Raise of $20M

Equillium triggered a $20 million milestone closing of a previously announced private placement following the dosing of the first patient in its Phase 1 clinical trial of EQ504. The company is issuing approximately 14.9 million shares and 20.1 million pre-funded warrants to institutional and accredited investors. The proceeds are expected to extend the company's cash runway into 2029.

Value
$20M
5:06 PM ET 8-K
Capital Raise Sculptor Diversified Real Estate Income Trust, Inc.

Sculptor Diversified Real Estate Income Trust Capital Raise

Sculptor Diversified Real Estate Income Trust announced its intention to conduct a private offering of two new share classes, Class II and Class SII common stock. In connection with the offering, the company increased its authorized capital stock to 2.6 billion shares and amended its advisory and operating partnership agreements to reflect the new share structure.

5:06 PM ET 10-Q
Financial Results Brown & Brown, Inc. BRO

Brown & Brown Q3 2026 Results: Net Income $240M, Up 5.7% YoY

Brown & Brown, Inc. reported 331,691,829 shares of common stock outstanding as of October 23, 2026. The filing highlights risks related to the acquisition of RSC Topco, Inc. (Accession), including increased indebtedness and integration challenges, while maintaining its status as a large accelerated filer.

Key figure
Net income $240M · +5.7% YoY
5:05 PM ET Form 4
Insider Buying Orion180 Insurance Group Inc. OIG

Orion180 Insurance Group Insider Craig Darling Buys $94.1K of Stock

Craig Darling bought 8,890 shares of Orion180 Insurance Group Inc. at $10.08 to $11.11 a share (average $10.58) in 4 transactions, worth $94.1K in total between Sep 22, 2026 and Sep 23, 2026. Shares held after the trade: 5,713,090 (+0.0%).

Value
$94.1K
Shares
8,890
Average price
$10.58
Holding change
+0.0%
Trade date
Sep 22, 2026 to Sep 23, 2026
5:05 PM ET Form 4
Insider Buying Nebius Group N.V. NBIS

Nebius Group Insider Arne Grimme Buys $122K of Stock

Arne Grimme bought 770 shares of Nebius Group N.V. at $153.96 to $161.97 a share (average $159.01) in 3 transactions, worth $122K in total between Oct 22, 2026 and Oct 26, 2026. Shares held after the trade: 7,398 (+2.9%).

Value
$122K
Shares
770
Average price
$159.01
Holding change
+2.9%
Trade date
Oct 22, 2026 to Oct 26, 2026
5:05 PM ET 8-K
Reverse Stock Split Onconetix, Inc. ONCO

Onconetix Reverse Stock Split

Onconetix, Inc. announced a 1-for-10 reverse stock split of its common stock, effective November 6, 2026. This follows a previous 1-for-10 split in May 2026, resulting in a cumulative 1-for-100 consolidation to reduce outstanding shares from approximately 5.9 million to 589,000. The action is intended to adjust the per-share trading price on the Nasdaq Capital Market.

5:04 PM ET 8-K
Capital Raise Apollo Infrastructure Co LLC

Apollo Infrastructure Co Capital Raise of $39.5M

Apollo Infrastructure Company LLC issued and sold unregistered shares across multiple series to third-party investors for approximately $39.5 million in cash. The company also updated its Transactional Net Asset Value (NAV) per share as of September 30, 2026, and announced its intention to conduct quarterly share repurchases for up to 5.0% of its aggregate NAV.

Value
$39.5M
5:04 PM ET 8-K
Financial Results Brown & Brown, Inc. BRO

Brown & Brown Financial Results

Brown & Brown, Inc. reported third quarter 2026 total revenues of $1.7 billion, a 7.4% increase year-over-year, driven by 1.2% organic revenue growth. Net income for the quarter rose 5.7% to $240 million, though diluted net income per share decreased slightly to $0.67.

Term
Q3 2026

“The third quarter reflected the incredible efforts of our teammates to win more customers in spite of a challenging rate environment. Our capabilities were broadly enhanced by the addition of approximately 5,000 new teammates from Accession, just over a year ago.”

J. Powell Brown, president and chief executive officer
5:04 PM ET 8-K
Financial Results Noble Corp plc NE

Noble Corp Financial Results

Noble Corporation reported Q3 2026 financial results with total revenue of $729 million and a net loss of $117 million. The company secured $560 million in new contract awards since July, bringing its total backlog to $6.7 billion, and declared a $0.50 per share quarterly dividend.

“The third quarter, which featured a 5% sequential decrease in Adjusted EBITDA, marked the successful resumption of operations for both of our rigs in Brazil, but was also impacted by several other rigs across the fleet transitioning between contracts. On the commercial front, we have recently secured approximately $560 million in new contract awards, including a number of key programs that support a strengthening fleet utilization profile as we move through 2027.”

Robert W. Eifler, President and Chief Executive Officer
5:02 PM ET 8-K
Stock Buyback New Mountain Finance Corp NMFC

New Mountain Finance Stock Buyback Update

New Mountain Finance Corporation's board of directors has approved a one-year extension of its existing $150 million stock repurchase program through December 31, 2027. The company has repurchased approximately $70 million worth of shares to date under the program, leaving $80 million in remaining authorization. The extension allows management to continue repurchasing shares in the open market if they believe the stock is undervalued due to market volatility.

Term
through Dec 2027
5:01 PM ET 10-Q
Financial Results Bone Biologics Corp BBLG

Bone Biologics Q3 2026 Results: Net Loss of $618K, Loss Narrows

Bone Biologics Corp reported a net loss of $2,157,341 for the nine months ended September 30, 2026, compared to a loss of $2,424,348 in the prior year period. The company remains in the development stage with zero revenue, focusing its expenditures on research and development for its NELL-1/DBM product candidate.

Key figure
Net loss $618K
5:01 PM ET 8-K
M&A Deal DataMeds AI, Inc. MEDS

DataMeds AI M&A Deal with EOS Technology Holdings, Inc.

DataMEDS AI entered into a second amended and restated non-binding letter of intent to acquire intellectual property assets from EOS and Scilex Holding Company, and a controlling interest in Tollo Health (d/b/a Health Lives Here). The transaction involves an exchange of membership interests and the issuance of common stock that will result in the counterparties owning approximately 89.5% of the company's common stock on a fully diluted basis.

Counterparty
EOS Technology Holdings, Inc.
5:01 PM ET 8-K
Loan & Debt Eva Live Inc GOAI

Eva Live $742K Debt Financing with Streeterville Capital, LLC

Eva Live Inc. received a notice from Streeterville Capital, LLC asserting that a 'Major Trigger Event' occurred under two secured convertible promissory notes due to a restricted issuance. As a result, Streeterville has elected to increase the outstanding balance of the notes by 10%, an estimated increase of approximately $741,786. The company disputes these assertions and the validity of the increase.

Value
$742K
Counterparty
Streeterville Capital, LLC
5:01 PM ET 8-K
Leadership Change XBP Global Holdings, Inc. XBP

XBP Global Holdings Leadership Change

Par Chadha, Chairman of the Board of Directors, notified XBP Global Holdings that he will not stand for re-election at the company's next annual meeting of stockholders. Mr. Chadha will continue to serve as Chairman until the expiration of his current term, and his departure is not due to any disagreement with the company.

5:01 PM ET 8-K
Financial Results Blue Ridge Bankshares, Inc. BRBS

Blue Ridge Bankshares Financial Results

Blue Ridge Bankshares reported a net loss of $4.2 million for the third quarter of 2026, primarily driven by an $8.5 million pre-tax provision for credit losses related to a legacy out-of-market hydroponic farming relationship. Despite the loss, the company noted improved operating performance with adjusted pre-tax earnings rising to $5.3 million and a pending merger with HomeTrust Bancshares expected to close in Q1 2027.

Term
Q3 2026

“With the regulatory consent order lifted in late 2025, our focus this year turned to soundness, profitability, and growth in our core community bank markets. Our third quarter results reflect continued quarterly improvements in loan growth, loan yields, deposit mix, and noninterest expense discipline. In addition, we further de-risked the balance sheet with a substantial charge-off on a legacy out-of-footprint relationship operating in the hydroponic farming business.”

Harry Golliday, interim president and chief executive officer
5:00 PM ET 8-K
Reverse Stock Split Fold Holdings, Inc. FLD

Fold Holdings Reverse Stock Split

Fold Holdings stockholders approved a proposal to authorize the Board of Directors to effect a reverse stock split of the company's common stock at a ratio between 1-for-2 and 1-for-50. The final decision on the exact ratio and timing remains at the discretion of the Board following this approval.

5:00 PM ET 8-K
Nasdaq/NYSE Compliance Notice YHN Acquisition I Ltd YHNAF

YHN Acquisition I Nasdaq/NYSE Compliance Notice

YHN Acquisition I Limited received a Staff Determination notice from Nasdaq on October 21, 2026, stating that the company failed to regain compliance with minimum market value requirements for continued listing. The company's board has decided not to appeal the delisting or transfer to the Nasdaq Capital Market, and trading is expected to be suspended on October 30, 2026. The company intends to apply for quotation on the OTC Markets following the delisting.

Counterparty
The Nasdaq Stock Market LLC
5:00 PM ET Form 4
Insider Selling Smartfinancial Inc. SMBK

Smartfinancial Director Steven B. Tucker Sells $173K of Stock

Steven B. Tucker, Director, sold 3,500 shares of Smartfinancial Inc. at $49.50 a share, worth $173K in total on Oct 23, 2026. Shares held after the trade: 47,222 (-6.9%).

Value
$173K
Shares
3,500
Price
$49.50
Role
Director
Holding change
-6.9%
Trade date
Oct 23, 2026
4:57 PM ET 8-K
Nasdaq/NYSE Compliance Notice Zeo Energy Corp. ZEO

Zeo Energy Nasdaq/NYSE Compliance Notice

Zeo Energy Corp. received a 180-day extension from Nasdaq, until April 19, 2027, to regain compliance with the $1.00 minimum bid price requirement. The company's Class A common stock will continue to trade on the Nasdaq Capital Market during this period while management monitors the stock price and considers options to meet the listing standard.

Counterparty
Nasdaq
Term
180 days
4:55 PM ET 8-K
Capital Raise Lycia Therapeutics, Inc. LYCA

Lycia Therapeutics Capital Raise

Lycia Therapeutics, Inc. filed its Amended and Restated Certificate of Incorporation and Bylaws in connection with the closing of its initial public offering. These governance changes were previously approved by the board and stockholders to take effect upon the IPO's completion.

4:55 PM ET 8-K
Financial Results Nucor Corp NUE

Nucor Financial Results

Nucor Corporation reported Q3 2026 net earnings of $1.32 billion on net sales of $11.25 billion, driven by strong demand and higher average selling prices in its steel mills segment. The company generated $2.7 billion in free cash flow year-to-date and achieved operational milestones including the first heat at its West Virginia sheet mill.

Term
Q3 2026

“I want to thank our teammates for delivering another strong quarter and making 2026 the safest summer in Nucor history. Supported by robust demand across key end markets, Nucor has generated approximately $2.7 billion of free cash flow and returned nearly $1.4 billion to shareholders through the first nine months of the year.”

Leon Topalian, Nucor’s Chair and Chief Executive Officer

“We also achieved important milestones in advancing our growth strategy, including the first heat at our West Virginia sheet mill in September and the recent start-up of our second galvanizing line at Nucor Steel Berkeley. These projects, together with other recent investments, are expanding Nucor’s capabilities and strengthening our position in attractive markets.”

Leon Topalian, Nucor’s Chair and Chief Executive Officer
4:54 PM ET 10-Q
Financial Results Bank of Hawaii Corp BOH

Bank of Hawaii Q3 2026 Results: Net Income $64.3M, Up 20.5% YoY

Bank of Hawaii reported net income of $64.3 million for the third quarter of 2026, an increase from $53.3 million in the same period of 2025. Total assets decreased slightly to $23.8 billion as of September 30, 2026, compared to $24.2 billion at year-end 2025, primarily driven by a reduction in cash and cash equivalents and held-to-maturity investment securities.

Key figure
Net income $64.3M · +20.5% YoY
4:53 PM ET 8-K
M&A Deal Rallybio Corp RLYB

Rallybio Signs $82.7M M&A Deal with Avenzo Therapeutics, Inc.

Rallybio Corporation provided a status update on its pending merger with Avenzo Therapeutics, declaring a special cash distribution of approximately $82.7 million ($13.56 per share) to stockholders. The distribution is based on the company's estimated net cash exceeding zero prior to the merger closing and is scheduled for payment on November 13, 2026.

Value
$82.7M
Counterparty
Avenzo Therapeutics, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.